Scripps Research Institute

Total Awards: 
Award Value: 
Institution type: 
Not for profit
Short Name: 

Awards to the Institution

Program Investigator Award Title Award Value
Tools and Technologies I Jeanne Loring The Stem Cell Matrix: a map of the molecular pathways that define pluripotent cells $1,133,552
Early Translational III Peter Schultz Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis $2,559,333
New Faculty I Kristin Baldwin Generating pluripotent cell lines from neurons. $2,786,560
Transplantation Immunology Nicholas Gascoigne Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance $1,705,554
Creativity Awards James Williamson Stem Cell Summer Academy: Creating the Next Generation of Scientists $205,122
Quest - Discovery Stage Research Projects Stuart Lipton Drug Development for Autism Spectrum Disorder Using Human Patient iPSCs $1,827,576
Early Translational II Peter Schultz Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis $6,047,249
Transplantation Immunology Jeanne Loring Thymus based tolerance to stem cell therapies $1,108,921
New Cell Lines Sheng Ding Derivation of New ICM-stage hESCs $936,973
Discovery Research Projects Stuart Lipton Repurposing Aminoadamantane Nitrate Compounds to Inhibit SARS-CoV-2 Viral Activity and to Protect the Brain from Viral-Related Damage $150,000
SEED Grant Peter Schultz A Chemical Approach to Stem Cell Biology $748,944
Shared Labs Sheng Ding TSRI Center for hESC Research $1,440,164
Research Training Grant Peter Schultz Training Scholars in Regenerative Medicine and Stem Cell Research $4,931,353
Early Translational I Jeanne Loring Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation $5,830,771
Basic Biology III Joel Gottesfeld Triplet Repeat Instability in Human iPSCs $1,705,494
New Faculty I Sheng Ding Reprogramming of human somatic cells back to pluripotent embryonic stem cells $1,393,876
Quest - Discovery Stage Research Projects Luke Lairson Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs $1,554,126
Early Translational I Martin Friedlander Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration $5,806,321
Basic Biology III Kristin Baldwin Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing $1,705,500
Tools and Technologies III Jeanne Loring User-friendly predictive molecular diagnostic assays for quality control of stem cell derivatives for transplantation and drug discovery $1,728,390
Quest - Discovery Stage Research Projects Michael Bollong Therapeutics to overcome the differentiation roadblock in Myelodysplastic Syndrome (MDS) $1,244,160
Shared Labs Jeanne Loring TSRI Center for hESC Research $3,725,070
Research Training II Ulrich Mueller Training Stem Cell Researchers at the Chemistry-Biology Interface $3,697,326
Quest - Discovery Stage Research Projects Jeanne Loring Autologous cell therapy for Parkinson’s disease using iPSC-derived DA neurons $2,299,786
Quest - Discovery Stage Research Projects Stuart Lipton Drug Development of Inhibitors of Inflammation Using Human iPSC-Derived Microglia (hiMG) $1,658,123
Tools and Technologies I Carlos Barbas Development of a novel technology for precise, efficient, and safe genetic modification of stem cells $1,138,548
Training Grant I-2 Peter Schultz Training Grant I $1,021,395
Conference Jeanne Loring World Stem Cell Summit $30,000
New Faculty I Kristin Baldwin Generating pluripotent cell lines from neurons. $2,786,560
Icon for XLSX export